PABC chosen by Brandwine Real Estate Trust to develop, launch and manage new B.Labs in Philadelphia
Brandywine Realty Trust (NYSE: BDN) in partnership with the Pennsylvania Biotechnology Center (PABC), on March 24 announced B.Labs—a Life Science incubator at Cira Centre directly adjacent to Brandywine’s 14 acre $3.5 billion Schuylkill Yards neighborhood in University City, Philadelphia. Please read more here.
Philly’s Bioscience Sector Is Driving the City’s Next Big Real Estate Boom
More than a million square feet of lab space are under construction to house the region’s leading life sciences companies and biotech entrepreneurs. Philadelphia’s life sciences sector is right about where Michael Jordan was in 1989. Please read more here.
How Philly’s Bioscience Sector Is Driving the City’s Next Big Real Estate Boom (Philadelphia Magazine)
In Bucks County, the Philadelphia Biotechnology Center (PABC), already home to 41 small-to-mid-size science, research and biotechnology companies, recently began construction on a new building to provide 15,000 square feet of new lab space, plus offices, conference rooms, and a 200-seat event hall. Please read more here.
Nobel Prize to Hepatitis B Foundation and Blumberg Institute Advisors
The Hepatitis B Foundation is celebrating the news that Harvey J. Alter, M.D., has been selected for the 2020 Nobel Prize in Physiology or Medicine, along with collaborators Michael Houghton, Ph.D., and Charles Rice, Ph.D. Please read more here.
Work begins on a $19 million expansion of the Pennsylvania Biotechnology Center (PABC)
Construction has begun on a $19 million expansion of the nonprofit PABC. The center’s leaders will join with local elected officials Sept. 17 to celebrate with a ceremonial “Construction Kickoff.” Please read more here.
PABC Entrepreneur Spotlight draws largest audience in its six-year history
More than 150 professionals in the life sciences, investment and related fields participated in the Sixth Annual “Entrepreneur Spotlight” on July 23, which was sponsored by the Pennsylvania Biotechnology Center (PABC). Please read more here.
The Role of Incubators in Cell and Gene Therapy Development
Working with incubators is a good idea for any biopharmaceutical company that is looking to expand its research, service, and consulting capabilities. Please read more here.
COVID-19 Research & Development
Numerous companies at PABC are engaged in R&D work on technologies for COVID-19 prevention, treatment and testing. Please read more here.
CB Celebration: Biotech Partnership from Central Bucks School District on Vimeo.
The Pennsylvania Biotechnology Center has partnered with Central Bucks School District to offer Advanced Placement Chemistry at our Center. In this unique program, students receive both classroom instruction and laboratory time with our scientists.
"It is enriching to have young people at our center learning about science," says John Kulp, PhD, Director of Academic Affairs. "We take the students into the lab to provide reality-based education, so they can take the principles that they are learning in the classroom portion of their studies, and see what professionals are doing in the laboratory."
DOYLESTOWN, PA (Nov. 8, 2019): Timothy M. Block, PhD, has been named to the Philadelphia Business Journal’s Power 100, a guide to the region’s most influential people. Dr. Block is President and Founder of the Pennsylvania Biotechnology Center, the national Hepatitis B Foundation, and its research arm, the Baruch S. Blumberg Institute, located in Doylestown, PA.
The annual Power 100 list is compiled by the Philadelphia Business Journal editorial team, and highlights those individuals that are making the biggest impact on the region. Dr. Block is being recognized for envisioning and creating the nonprofit Pennsylvania Biotechnology Center (PABC) in 2006, and growing it into a home for nearly 50 companies, employing hundreds of scientists in our region. PABC’s unique nonprofit business model provides a nurturing environment to help small life sciences startups develop into successful companies. Today, the companies at PABC are collectively valued at more than $1.5 billion. PABC was named one of the most successful biotechnology incubators in the country according to an independent study conducted in 2018.
